← Back to Dashboard

Zanamivir

Neuraminidase inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N
ARAIBEBZBOPLMB-UFGQHTETSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus5

Influenza virus
Influenza
Target: Neuraminidase
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapan
Approval ref: AntiviralDbApproval ref (pmda.go.jp)
Influenza A virus
FLUAV
Target: Viral neuraminidase
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapan
Approval ref (pmda.go.jp) DB00558
Influenza B virus
FLUBV
Target: Viral neuraminidase
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapan
Approval ref (pmda.go.jp) DB00558
Human respirovirus 3
HPIV-3
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (pmda.go.jp) PMID:29477132
Parechovirus A
HPEV-3
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (pmda.go.jp) PMID:12477836